Linda M. Niccolai1, Abby L. Hochberg
2, Jessica B. Lewis
1, Kathleen A. Ethier
3, and Jeannette R. Ickovics
1. (1) Epidemiology and Public Health, Yale University, 60 College Street, New Haven, CT, USA, (2) Yale School of Medicine, New Haven, CT, USA, (3) Centers for Disease Control and Prevention, Atlanta, GA, USA
Background:
Young women are at especially high risk for sexually transmitted infections (STI). Chlamydia trachomatis (C. trachomatis) is the most commonly diagnosed bacterial STI in this population.
Objective:
To determine patterns of repeat C. trachomatis infections after an initial diagnosis in a cohort of young women using multiple sources of data.
Method:
From 1998 – 2002, 411 adolescent women ages 14 to 19 years were recruited from 10 community-based health centers and followed for 23,318 person-months (average 4.7 years per person) using a variety of methods including urine-based screening for C. trachomatis infections, face-to-face interviews, medical record reviews, and a review of state health department reports of C. trachomatis infections. Repeat infections were defined as a diagnosis that occurred more than 30 days after an initial diagnosis.
Result:
The sample was an average 17.3 years of age, and 40% black and 36% Latina. A total of 216 (53%) participants were diagnosed with C. trachomatis during the study period, and 123 (30% of total sample and 57% of those with initial infections) were diagnosed with repeat C. trachomatis. Over half of all diagnoses made were repeat infections (53% = 241/456). The rate of repeat infections was 42.1 per 1,000 person-months. The median time to repeat infection was 5.2 months. Younger (age 14-16 years) and older adolescents (17-19 years) had similar frequencies of repeat infections.
Conclusion:
Repeat C. trachomatis infections comprise a substantial health burden in young women. Using multiple data sources, we found higher estimates than previously reported.
Implications:
Repeat C. trachomatis infections are of clinical and public health concern because of the link to pelvic inflammatory disease, chronic pelvic pain, and infertility. Treatment guidelines include a recommendation to advise all women with C. trachomatis infections to be re-screened 3-4 months after treatment; the results of this study underscore its importance.